DateNov. 23(Wed) 09:00~16:00
PlaceLotte Hotel Seoul, Sapphire Ballroom,(3F) Seoul, Korea
OrganizersNews1 / KRIBB
| 09:00~09:40 |
Opening |
Baek kyu LeeCEO, News1 |
| 09:40~10:10 |
Key note Speech |
Jane LeongVice President(Medical Affairs, Asia Pacific), Moderna |
| 10:10~10:30 |
BIO Trend① |
Seng Ho JeonCEO, Daewoong Pharmaceutical |
| 10:30~11:10 |
BIO Trend② |
Rosa(Heejung) KimR&D Scientific and Clinical Alliance Lead Director(Asia), AstraZeneca Sang Hoon LeeCEO, ABLBio |
| 11:10~12:00 |
Discussion |
Chair & Participants : Mahn Soon HwangCEO, Korea Investment Partners Participants : Lambert Chanwoo KukGroup Head, KB investment Participants : Seung Woo LeeExecutive Director, Devsisters Ventures Participants : Hyun Woo ParkInvestment manager, Timefolio Asset Management |
| 12:00~13:20 |
Lunch |
|
| 13:20~13:50 |
Afternoon Session |
James ChoiExecutive VP, Chief Information and Marketing Officer at Samsung Biologics |
| 13:50~14:50 |
IR Session |
Hak Bae ChoiCEO, Haplnscience Jade KimCEO, Inventage Lab Byong Hwa LeeCEO, Toolgene Chang-Hwan KimExecutive VP, ProtiumScience |
| 14:50~15:00 |
Break |
|
| 15:00~16:00 |
IR Session |
Seung Jae LeeCEO, C&L Therapeutics Tea Jin KangCEO, Renhaim Therapeutics Dong Sik HamDirector, Advanced Biopharmaceuticals, SCM Lifescience Chae Ok YunCEO, Genemedicine |
※ The above schedule is subject to change.